Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial
Q. Li, J. Chalmers, S. Czernichow, B. Neal, B. A. Taylor, S. Zoungas, N. Poulter, M. Woodward, A. Patel, B. de Galan, G. D. Batty, on behalf of the ADVANCE Collaborative groupVolume:
53
Language:
english
Pages:
8
DOI:
10.1007/s00125-010-1862-1
Date:
November, 2010
File:
PDF, 145 KB
english, 2010